Clinical Trial Update: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety, tolerability, pharmacokinetics, and activity of GS-9450 in subjects with chronic hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-9450

Snippet

Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 2 | Status: COMPLETED